Emil Jernstedt Barkovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emil Jernstedt Barkovich has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Camilo Jaimes
Department of Radiology, Massachusetts General Hospital, Boston, United States
3 shared publications - Fedel Machado-Rivas
Massachusetts General Hospital, Boston, USA
3 shared publications - Onur Afacan
Department of Radiology Boston Children's Hospital Boston Massachusetts USA
3 shared publications - Arman Avesta
Massachusetts General Hospital, Boston, USA
2 shared publications - Karen Buch
Department of Radiology, Massachusetts General Hospital, Boston, MA
2 shared publications - Samuel C. D. Cartmell
Massachusetts General Hospital, Boston, USA
2 shared publications
Latest Publications
- 21 September 2026
- Published by Elsevier in Oral Oncology
- Vol. 182
Accuracy of radiographic nodal counts in HPV-positive oropharyngeal cancer and impact on treatment
- 21 September 2026
- Published by Elsevier in Oral Oncology
- Vol. 182
Accuracy of radiographic nodal counts in HPV-positive oropharyngeal cancer and impact on treatment
- 3 June 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (6) , 1731-1736
Indeterminate T1-Hypointense Spine Lesions: Prevalence of Malignancy in the Absence of Aggressive Imaging Features
T1-hypointense bone lesions are commonly encountered on spine MRI and lack consensus for appropriate management. This study assessed the outcomes of indeterminate low-T-signal vertebral lesions to better inform follow-up management decisions. This institutional review board-approved retrospective study was conducted on individuals who underwent a spine MRI between 2017 and 2025 on which an osseous lesion was reported as "indeterminate." Five hundred thirty-eight examinations were reviewed, and lesion signal characteristics and follow-up were collected. Lesions were categorized as stable, no follow-up, incomplete follow-up, benign or degenerative on CT/MRI follow-up, or malignant. A minimum interval of 24 months was required for stability, with incomplete follow-up defined as 2-24 months. Lesions were also classified as stable if a CT performed >2 years later demonstrated no change or no detectable abnormality. Cancer history was categorized as no known malignancy, prior or active malignancy without metastatic disease, and confirmed metastatic disease. Examinations were excluded if there was incomplete imaging or a known history of metastasis to bone. Two hundred seventy-eight lesions met the inclusion criteria, of which 58% had ≥2 months' follow-up. Sixty-one percent were T1-isointense to skeletal muscle, 34% were hyperintense, and 5% were hypointense. Sixty-three percent of patients with follow-up had no malignancy history, and 9% had metastatic disease. Of lesions with follow-up, 55% were stable at ≥2 years, 33% were unchanged at 2-24 months, and 10% were typically benign or degenerative on follow-up. Three cases (2%) were malignant, all diagnoses of new bone metastases in the setting of known or concurrently diagnosed metastatic disease. All lesions were isointense to muscle on T1WI and hyperintense to marrow on STIR images. Low-T1-signal bone lesions are typically benign in the absence of aggressive features or extraskeletal metastatic disease. Primary malignant osseous spine tumors are very rare, with none present in our cohort. The Society of Skeletal Radiology Bone Reporting and Data System suggested follow-up timing may not be appropriate for spine lesions, given the increased prevalence of both benign and metastatic lesions relative to primary bone tumors. Six to 12 weeks may be more reasonable follow-up timing when there is elevated concern for metastasis; follow-up may not be necessary in low-risk populations.
- 3 June 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (6) , 1731-1736
Indeterminate T1-Hypointense Spine Lesions: Prevalence of Malignancy in the Absence of Aggressive Imaging Features
T1-hypointense bone lesions are commonly encountered on spine MRI and lack consensus for appropriate management. This study assessed the outcomes of indeterminate low-T-signal vertebral lesions to better inform follow-up management decisions. This institutional review board-approved retrospective study was conducted on individuals who underwent a spine MRI between 2017 and 2025 on which an osseous lesion was reported as "indeterminate." Five hundred thirty-eight examinations were reviewed, and lesion signal characteristics and follow-up were collected. Lesions were categorized as stable, no follow-up, incomplete follow-up, benign or degenerative on CT/MRI follow-up, or malignant. A minimum interval of 24 months was required for stability, with incomplete follow-up defined as 2-24 months. Lesions were also classified as stable if a CT performed >2 years later demonstrated no change or no detectable abnormality. Cancer history was categorized as no known malignancy, prior or active malignancy without metastatic disease, and confirmed metastatic disease. Examinations were excluded if there was incomplete imaging or a known history of metastasis to bone. Two hundred seventy-eight lesions met the inclusion criteria, of which 58% had ≥2 months' follow-up. Sixty-one percent were T1-isointense to skeletal muscle, 34% were hyperintense, and 5% were hypointense. Sixty-three percent of patients with follow-up had no malignancy history, and 9% had metastatic disease. Of lesions with follow-up, 55% were stable at ≥2 years, 33% were unchanged at 2-24 months, and 10% were typically benign or degenerative on follow-up. Three cases (2%) were malignant, all diagnoses of new bone metastases in the setting of known or concurrently diagnosed metastatic disease. All lesions were isointense to muscle on T1WI and hyperintense to marrow on STIR images. Low-T1-signal bone lesions are typically benign in the absence of aggressive features or extraskeletal metastatic disease. Primary malignant osseous spine tumors are very rare, with none present in our cohort. The Society of Skeletal Radiology Bone Reporting and Data System suggested follow-up timing may not be appropriate for spine lesions, given the increased prevalence of both benign and metastatic lesions relative to primary bone tumors. Six to 12 weeks may be more reasonable follow-up timing when there is elevated concern for metastasis; follow-up may not be necessary in low-risk populations.
- 28 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (9) , 1780-1785
Contrast-Enhanced Brain MRI for Ambulatory Evaluation of Headache: Comprehensive or Excessive?
BACKGROUND AND PURPOSE: Headache is one of the most common indications for brain MR imaging. Our purpose was to assess the necessity and yield of contrast-enhanced brain MRI protocols relative to noncontrast protocols for the outpatient evaluation of headache in adults. MATERIALS AND METHODS: We retrospectively reviewed 874 consecutive adult outpatient brain contrast-enhanced MRIs for the indication of headache. Examination impressions were reviewed for any findings contributing to headache and stratified into 18 categories. Incidental findings unrelated to headache but mentioned in the report impressions were recorded. A subset of 100 contrast-relevant cases were selected for independent blinded review by 2 neuroradiologists first without contrast and then after a 3-week washout period, with and without contrast. Reviewers were asked to classify cases as positive/negative and to describe relevant findings. Specific diagnoses were compared between reviews and readers on a case-by-case basis. Intrareader agreement was calculated between noncontrast and postcontrast reviews. RESULTS: Eighteen percent of examinations had findings potentially related to headaches. Two percent of cases were deemed contrast relevant. Incidental findings were reported in 4% of cases. On the blinded double review, the percentage of positive cases remained essentially unchanged, decreasing by 1.5% with contrast-enhanced images available. All intra- and extra-axial masses associated with parenchymal edema were detected without contrast. Detection rate of small, incidental meningiomas doubled on postcontrast sequences. CONCLUSIONS: Routine acquisition of contrast-enhanced MRIs for outpatients with an indication of headache had a low yield. Noncontrast examinations demonstrated similar sensitivity for actionable intracranial pathology, while contrast-enhanced MRIs doubled the detection rate of incidental meningiomas. A more practical initial approach may be starting with noncontrast examinations with callbacks or additional imaging for a small percentage of patients.
- 28 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (9) , 1780-1785
Contrast-Enhanced Brain MRI for Ambulatory Evaluation of Headache: Comprehensive or Excessive?
BACKGROUND AND PURPOSE: Headache is one of the most common indications for brain MR imaging. Our purpose was to assess the necessity and yield of contrast-enhanced brain MRI protocols relative to noncontrast protocols for the outpatient evaluation of headache in adults. MATERIALS AND METHODS: We retrospectively reviewed 874 consecutive adult outpatient brain contrast-enhanced MRIs for the indication of headache. Examination impressions were reviewed for any findings contributing to headache and stratified into 18 categories. Incidental findings unrelated to headache but mentioned in the report impressions were recorded. A subset of 100 contrast-relevant cases were selected for independent blinded review by 2 neuroradiologists first without contrast and then after a 3-week washout period, with and without contrast. Reviewers were asked to classify cases as positive/negative and to describe relevant findings. Specific diagnoses were compared between reviews and readers on a case-by-case basis. Intrareader agreement was calculated between noncontrast and postcontrast reviews. RESULTS: Eighteen percent of examinations had findings potentially related to headaches. Two percent of cases were deemed contrast relevant. Incidental findings were reported in 4% of cases. On the blinded double review, the percentage of positive cases remained essentially unchanged, decreasing by 1.5% with contrast-enhanced images available. All intra- and extra-axial masses associated with parenchymal edema were detected without contrast. Detection rate of small, incidental meningiomas doubled on postcontrast sequences. CONCLUSIONS: Routine acquisition of contrast-enhanced MRIs for outpatients with an indication of headache had a low yield. Noncontrast examinations demonstrated similar sensitivity for actionable intracranial pathology, while contrast-enhanced MRIs doubled the detection rate of incidental meningiomas. A more practical initial approach may be starting with noncontrast examinations with callbacks or additional imaging for a small percentage of patients.
- 21 April 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1071-1087
A closer look: pediatric neuroimaging at 7T
Although 7 Tesla (7T) field strength MR imaging offers higher signal-to-noise ratio and spatial resolution and improves certain types of tissue contrast, the incorporation of these systems into clinical pediatric neuroradiology has been relatively limited. Following a discussion of available hardware, current regulations, and pediatric specific safety considerations, this article briefly reviews the underlying principles behind the improved image quality attainable with certain techniques at 7T. Subsequently, specific high-performance sequences and techniques are highlighted including MP2RAGE, T2-weighted, and T2*-weighted sequences as well as MR angiography, all with sample images and comparison with standard field strengths. Finally, current clinical neuroradiological applications of 7T are explored with particular focus on focal epilepsy, multiple sclerosis, vascular diseases, and cerebral microbleeds. Ongoing and future innovations in hardware design and sequence development promise continued advancement in 7T neuroimaging and further applications to pediatric neuroradiology.
- 21 April 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1071-1087
A closer look: pediatric neuroimaging at 7T
Although 7 Tesla (7T) field strength MR imaging offers higher signal-to-noise ratio and spatial resolution and improves certain types of tissue contrast, the incorporation of these systems into clinical pediatric neuroradiology has been relatively limited. Following a discussion of available hardware, current regulations, and pediatric specific safety considerations, this article briefly reviews the underlying principles behind the improved image quality attainable with certain techniques at 7T. Subsequently, specific high-performance sequences and techniques are highlighted including MP2RAGE, T2-weighted, and T2*-weighted sequences as well as MR angiography, all with sample images and comparison with standard field strengths. Finally, current clinical neuroradiological applications of 7T are explored with particular focus on focal epilepsy, multiple sclerosis, vascular diseases, and cerebral microbleeds. Ongoing and future innovations in hardware design and sequence development promise continued advancement in 7T neuroimaging and further applications to pediatric neuroradiology.
- Open Access
- 28 March 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1148
Correction: Optimizing T2* imaging for adolescent and young adult patients at 7 T
- 28 March 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1148
Open AccessCorrection: Optimizing T2* imaging for adolescent and young adult patients at 7 T
- 17 March 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1138-1147
Optimizing T2* imaging for adolescent and young adult patients at 7 T
Background T2*-weighted imaging at 7 T offers detailed visualization of brain structures, but image quality and artifacts depend on echo time (TE) adjustments. Optimizing TE is crucial for tissue contrast and artifact minimization. Objective To evaluate the impact of TE on tissue contrast and image quality in T2*-weighted sequences at 7 T in adolescents and young adults. Materials and methods Ten adolescent and young adult patients underwent 7-T MRI with multi-echo T2*-weighted sequences. Six TEs (8.1 ms to 36 ms) were acquired. Signal contrast ratios (CR) for seven brain regions—caudate nuclei, corpus callosum genu, frontal cortex, cortical veins, globi pallidi, medullary veins, and left optic radiation—were analyzed. Two blinded neuroradiologists assessed image quality and artifact severity using a 4-point Likert scale (IQS). Statistical trends were analyzed using the Jonckheere-Terpstra test. A P-value < 0.05 was considered statistically significant. Results The study cohort consisted of 4 male and 6 females; the median age of the patients was 16 years (range 15–23 years). CR increased significantly with higher TEs for most regions except the caudate, where CR decreased (P < 0.05). Longer TEs led to greater artifact severity in the brainstem, temporal, occipital, and frontal lobes (P < 0.02), but not in parietal lobes (P > 0.05). Kappa agreement for IQS was 0.76. Conclusion TE significantly affects contrast and artifacts in 7-T T2*-weighted imaging. TEs between 20 and 30 ms offer the best balance between tissue contrast and artifact severity, optimizing image quality for clinical and research applications. Graphical abstract
- 17 March 2025
- Published by Springer Nature in Pediatric Radiology
- Vol. 55 (6) , 1138-1147
Optimizing T2* imaging for adolescent and young adult patients at 7 T
Background T2*-weighted imaging at 7 T offers detailed visualization of brain structures, but image quality and artifacts depend on echo time (TE) adjustments. Optimizing TE is crucial for tissue contrast and artifact minimization. Objective To evaluate the impact of TE on tissue contrast and image quality in T2*-weighted sequences at 7 T in adolescents and young adults. Materials and methods Ten adolescent and young adult patients underwent 7-T MRI with multi-echo T2*-weighted sequences. Six TEs (8.1 ms to 36 ms) were acquired. Signal contrast ratios (CR) for seven brain regions—caudate nuclei, corpus callosum genu, frontal cortex, cortical veins, globi pallidi, medullary veins, and left optic radiation—were analyzed. Two blinded neuroradiologists assessed image quality and artifact severity using a 4-point Likert scale (IQS). Statistical trends were analyzed using the Jonckheere-Terpstra test. A P-value < 0.05 was considered statistically significant. Results The study cohort consisted of 4 male and 6 females; the median age of the patients was 16 years (range 15–23 years). CR increased significantly with higher TEs for most regions except the caudate, where CR decreased (P < 0.05). Longer TEs led to greater artifact severity in the brainstem, temporal, occipital, and frontal lobes (P < 0.02), but not in parietal lobes (P > 0.05). Kappa agreement for IQS was 0.76. Conclusion TE significantly affects contrast and artifacts in 7-T T2*-weighted imaging. TEs between 20 and 30 ms offer the best balance between tissue contrast and artifact severity, optimizing image quality for clinical and research applications. Graphical abstract
- 24 November 2024
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (4) , 506-510
Abnormal cochlear enhancement in Norrie disease
Norrie disease (ND) is a rare x-linked disease with retinal and cochlear vascular abnormalities. Clinically, it is characterized by congenital blindness and progressive sensorineural hearing loss during adolescence. We present images of a 3 year old child with ND and normal hearing demonstrating bilateral cochlear enhancement on brain MRI, a finding which has not been previously reported. ND mouse models show progressive degeneration of the endolymph-producing stria vascularis (SV); we hypothesize that these changes allow gadolinium leakage into the endolymph. Our images indicate that cochlear enhancement precedes changes in hearing and suggest that temporal bone/internal auditory canal MR imaging should be considered in the evaluation of ND. Future studies are needed to characterize the temporal evolution of this cochlear enhancement and how it corresponds with hearing loss. Mouse models suggest that it may be a transient phenomenon and diminish as the SV degenerates further. As ND gene therapy trials approach clinical use, cochlear enhancement could aid candidate selection and provide insight into treatment effect.
- 24 November 2024
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (4) , 506-510
Abnormal cochlear enhancement in Norrie disease
Norrie disease (ND) is a rare x-linked disease with retinal and cochlear vascular abnormalities. Clinically, it is characterized by congenital blindness and progressive sensorineural hearing loss during adolescence. We present images of a 3 year old child with ND and normal hearing demonstrating bilateral cochlear enhancement on brain MRI, a finding which has not been previously reported. ND mouse models show progressive degeneration of the endolymph-producing stria vascularis (SV); we hypothesize that these changes allow gadolinium leakage into the endolymph. Our images indicate that cochlear enhancement precedes changes in hearing and suggest that temporal bone/internal auditory canal MR imaging should be considered in the evaluation of ND. Future studies are needed to characterize the temporal evolution of this cochlear enhancement and how it corresponds with hearing loss. Mouse models suggest that it may be a transient phenomenon and diminish as the SV degenerates further. As ND gene therapy trials approach clinical use, cochlear enhancement could aid candidate selection and provide insight into treatment effect.
- 10 August 2024
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 54 (2) , 167-169
Beyond milestones and percentiles: Revisiting non-cognitive and non-interpretive skills in radiology
- 10 August 2024
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 54 (2) , 167-169
Beyond milestones and percentiles: Revisiting non-cognitive and non-interpretive skills in radiology
- 9 June 2023
- Published by Springer Nature in Emergency Radiology
- Vol. 30 (4) , 525-537
Pearls and pitfalls in emergency CT neuroangiography through the lens of bias and error
Computed tomography angiography (CTA) of the head and neck is central in emergency department (ED) evaluation of clinically suspected acute stroke and intracranial hemorrhage. Timely and accurate detection of acute findings is crucial for best clinical outcomes; missed or delayed diagnosis can be devastating. Our pictorial essay presents twelve CTA cases that provided significant diagnostic dilemmas to on-call trainees while reviewing current bias and error classifications in radiology. Among others, we discuss anchoring, automation, framing, satisfaction of search, scout neglect and zebra-retreat bias. Each imaging vignette depicts a potential diagnostic “pitfall” while introducing types of cognitive bias/error before concluding with a concrete “pearl” for CTA interpretation. We believe that familiarity with bias and error is particularly important in the ED setting where high case volume, high acuity and radiologist fatigue intersect. Particular attention to personal cognitive biases and these potential CTA pitfalls may help emergency radiologists transition from habit-driven pattern recognition to analytical thinking, ultimately improving diagnostic decision making.
- 9 June 2023
- Published by Springer Nature in Emergency Radiology
- Vol. 30 (4) , 525-537
Pearls and pitfalls in emergency CT neuroangiography through the lens of bias and error
Computed tomography angiography (CTA) of the head and neck is central in emergency department (ED) evaluation of clinically suspected acute stroke and intracranial hemorrhage. Timely and accurate detection of acute findings is crucial for best clinical outcomes; missed or delayed diagnosis can be devastating. Our pictorial essay presents twelve CTA cases that provided significant diagnostic dilemmas to on-call trainees while reviewing current bias and error classifications in radiology. Among others, we discuss anchoring, automation, framing, satisfaction of search, scout neglect and zebra-retreat bias. Each imaging vignette depicts a potential diagnostic “pitfall” while introducing types of cognitive bias/error before concluding with a concrete “pearl” for CTA interpretation. We believe that familiarity with bias and error is particularly important in the ED setting where high case volume, high acuity and radiologist fatigue intersect. Particular attention to personal cognitive biases and these potential CTA pitfalls may help emergency radiologists transition from habit-driven pattern recognition to analytical thinking, ultimately improving diagnostic decision making.